Akira Kagayama

1.6k total citations
45 papers, 1.3k citations indexed

About

Akira Kagayama is a scholar working on Spectroscopy, Oncology and Pharmacology. According to data from OpenAlex, Akira Kagayama has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Spectroscopy, 14 papers in Oncology and 14 papers in Pharmacology. Recurrent topics in Akira Kagayama's work include Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (10 papers) and Analytical Chemistry and Chromatography (8 papers). Akira Kagayama is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (10 papers) and Analytical Chemistry and Chromatography (8 papers). Akira Kagayama collaborates with scholars based in Japan, Saudi Arabia and Iraq. Akira Kagayama's co-authors include Shigeyuki Terashita, Y. Naritomi, Katsunosuke Machida, Sumihisa Kimura, Yoichi Naritomi, Akira Suzuki, Toshifumi Shiraga, Yutaka Saito, Yuichi Sugiyama and Toshiro Niwa and has published in prestigious journals such as British Journal of Pharmacology, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Akira Kagayama

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akira Kagayama Japan 20 475 365 278 263 113 45 1.3k
Matthew Wright United States 25 284 0.6× 352 1.0× 472 1.7× 151 0.6× 174 1.5× 85 1.8k
Hai‐Zhi Bu United States 18 371 0.8× 175 0.5× 277 1.0× 201 0.8× 98 0.9× 36 986
Richard A. Morrison United States 18 190 0.4× 379 1.0× 405 1.5× 293 1.1× 105 0.9× 52 1.4k
Xiaomei Zhuang China 20 304 0.6× 266 0.7× 534 1.9× 144 0.5× 90 0.8× 96 1.6k
Lori H. Takahashi United States 12 176 0.4× 473 1.3× 449 1.6× 171 0.7× 219 1.9× 17 1.3k
Susanne Winiwarter Sweden 19 261 0.5× 439 1.2× 510 1.8× 293 1.1× 482 4.3× 40 1.6k
Per Garberg Sweden 14 203 0.4× 531 1.5× 411 1.5× 77 0.3× 80 0.7× 25 1.3k
Sang M. Chung United States 13 156 0.3× 322 0.9× 679 2.4× 122 0.5× 68 0.6× 15 1.5k
Eszter Hazai Hungary 23 283 0.6× 442 1.2× 801 2.9× 125 0.5× 286 2.5× 46 1.8k
William M. Atkins United States 21 802 1.7× 458 1.3× 994 3.6× 285 1.1× 216 1.9× 43 1.9k

Countries citing papers authored by Akira Kagayama

Since Specialization
Citations

This map shows the geographic impact of Akira Kagayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Kagayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Kagayama more than expected).

Fields of papers citing papers by Akira Kagayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Kagayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Kagayama. The network helps show where Akira Kagayama may publish in the future.

Co-authorship network of co-authors of Akira Kagayama

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Kagayama. A scholar is included among the top collaborators of Akira Kagayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Kagayama. Akira Kagayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shiraga, Toshifumi, et al.. (2005). Identification of Cytochrome P450 Enzymes Involved in the Metabolism of FK228, a Potent Histone Deacetylase Inhibitor, in Human Liver Microsomes. Biological and Pharmaceutical Bulletin. 28(1). 124–129. 32 indexed citations
3.
Niwa, Toshiro, Toshifumi Shiraga, Yasuo Ohno, & Akira Kagayama. (2005). Interindividual Variability in 5-Fluorouracil Metabolism and Procainamide N-Acetylation in Human Liver Cytosol. Biological and Pharmaceutical Bulletin. 28(6). 1071–1074. 10 indexed citations
5.
Ishikawa, Takeshi, Fusako Nishigaki, Susumu Miyata, et al.. (2004). Prevention of progressive joint destruction in collagen‐induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031. British Journal of Pharmacology. 144(1). 133–143. 49 indexed citations
7.
Niwa, Toshiro, Toshifumi Shiraga, T. Hashimoto, & Akira Kagayama. (2004). Effect of Cefixime and Cefdinir, Oral Cephalosporins, on Cytochrome P450 Activities in Human Hepatic Microsomes. Biological and Pharmaceutical Bulletin. 27(1). 97–99. 13 indexed citations
8.
Tozuka, Zenzaburo, Toshifumi Shiraga, Yasuyuki Mitani, et al.. (2003). Strategy for structural elucidation of drugs and drug metabolites using (MS)n fragmentation in an electrospray ion trap. Journal of Mass Spectrometry. 38(8). 793–808. 43 indexed citations
9.
Niwa, Toshiro, et al.. (2003). In vitroactivation of 7-benzyloxyresorufinO-debenzylation and nifedipine oxidation in human liver microsomes. Xenobiotica. 33(7). 717–729. 37 indexed citations
10.
Tozuka, Zenzaburo, et al.. (2003). New SRM Data Dependent Exclusion (MS)n Measurement for Structural Determination of Drug Metabolites Using LC/ESI/Ion Trap MS. Drug Metabolism and Pharmacokinetics. 18(6). 390–403. 5 indexed citations
11.
Suzuki, Akira, et al.. (2002). Metabolites of micafungin in rats and dogs. 50. 88–93. 8 indexed citations
12.
Katashima, Masataka, et al.. (2002). Distribution and excretion after intravenous dosing of [^ C] micafungin to rats. 50. 80–87. 4 indexed citations
13.
Tozuka, Zenzaburo, et al.. (2002). Strategy for Structure Elucidation of Drug Metabolites Derived from Protonated Molecules and (MS)n Fragmentation of Zotepine, Tiaramide and their Metabolites. Drug Metabolism and Pharmacokinetics. 17(4). 316–339. 8 indexed citations
14.
Tokunaga, Yuji, et al.. (1995). Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. 562–563. 7 indexed citations
15.
Kagayama, Akira, et al.. (1993). Oral Absorption of FK506 in Rats. Pharmaceutical Research. 10(10). 1446–1450. 35 indexed citations
19.
Kagayama, Akira, et al.. (1984). Mechanism of diffusion of compounds through ethylene vinyl acetate copolymers I. Kinetics of diffusion of l-chloro-4-nitrobenzene, 3,4-dimethylphenol and 4-hexylresorcinol. International Journal of Pharmaceutics. 18(3). 247–258. 16 indexed citations
20.
Machida, Katsunosuke, Akira Kagayama, & Yutaka Saito. (1978). Polarized Raman spectra and intermolecular potential of DL‐alanine crystal. Journal of Raman Spectroscopy. 7(4). 188–193. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026